BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as heart attack and stroke. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was incorporated in 2000 and is headquartered in Waltham, Massachusetts.
Frequently asked questions
What sector does BG Medicine Inc (BGMD) operate in?
BG Medicine Inc belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is BG Medicine Inc (BGMD) current stock price?
As of the latest data, BG Medicine Inc stock price is $0.00, with a previous close of $0.00.
What is BG Medicine Inc (BGMD) current market capitalization?
BG Medicine Inc market cap is approximately 1.14 thousand.
Does BG Medicine Inc (BGMD) pay dividends?
No. BG Medicine Inc does not pay a dividend.
What is BG Medicine Inc (BGMD) beta (volatility) score?
BG Medicine Inc has a beta of 65.168, indicating very high volatility compared to the market.